Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

VitaNova Life Sciences (YJGJ) Accumulated Expenses (2017 - 2026)

VitaNova Life Sciences (YJGJ) has disclosed Accumulated Expenses for 4 consecutive years, with $68713.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Expenses changed N/A year-over-year to $68713.0, compared with a TTM value of $68713.0 through Oct 2025, changed N/A, and an annual FY2025 reading of $60065.0, changed N/A over the prior year.
  • Accumulated Expenses was $68713.0 for Q4 2025 at VitaNova Life Sciences, up from $60065.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $68713.0 in Q4 2025 and bottomed at $60065.0 in Q2 2025.